Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Barbara G. McClung

At a glance: Barbara G. McClung is General Counsel at Caribou Biosciences (CRBU). Their latest SEC Form 4, filed Feb 24, 2026, reported a sale of $14K. On file: 0 purchase lines ($0) and 1 sale line ($14K).

Disclosed holdings: about $149K of CRBU stock: 481,564 shares reported on their latest Form 4 (filed Feb 24, 2026), valued at the Nov 19, 2026 close of $0.31. This counts only CRBU shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

General Counsel at Caribou Biosciences, Inc. (CRBU)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $14K

Barbara G. McClung's InsiderPrint

3 trades from SEC Form 4 filings, 2021 to 2026, drawn as one fingerprint.

InsiderPrint of Barbara G. McClung: 3 trades, 2021 to 20262021: 2 buys, 0 sales2022: 0 buys, 0 sales2023: 0 buys, 0 sales2024: 0 buys, 0 sales2025: 0 buys, 0 sales2026: 0 buys, 1 sale

Reading this print: Mostly buys, trading about once a year, typically $16K a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (2)
  • Dent inward: a sale (1)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. William L. YankusDirector · KINS · 100% match
  2. Martin GarmendiaSee Remarks · ASLE · 99% match
  3. Stuart A. TrossChief People & Workpl Officer · MNKD · 98% match
  4. Scott Robert HenryDirector · NXGL · 95% match
  5. Francis S. Soistman Jr.Director · EHTH · 95% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Every purchase since 2021

From the SEC's insider data sets: each open-market buy by Barbara G. McClung, matched to how the stock did over the next 90 days against the S&P 500.

0 of 1 buy beat the S&P 500 (0%), median -39.7% vs. the index. Small sample: treat with care. All insider buys: 46%.

StockFiled90 days vs. S&P 500
CRBUDec 8, 2021-39.7%

Buys made close together in one stock count once. Price-only returns; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Feb 24SEC CRBUCaribou Biosciences, Inc. Sell Plan 6,938481,564 held (−1%) $1.96 $14K -84.3%
  • Sell

    General Counsel Barbara G Mcclung sold $14K of CRBU at $1.96 — pre-scheduled 10b5-1 plan sale.

Follow Barbara G. McClung

Get one email when Barbara G. McClung files a new purchase or sale. Free.

At most one email a day about Barbara G. McClung, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.